title: Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul, 135-710, Korea.
authors.forename: S-H
authors.initials: SH
authors.lastname: Lee
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: J
authors.initials: J
authors.lastname: Park
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: K-E
authors.initials: KE
authors.lastname: Lee
authors.forename: S I
authors.initials: SI
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Nam
authors.forename: J O
authors.initials: JO
authors.lastname: Park
authors.forename: K
authors.initials: K
authors.lastname: Kim
authors.forename: C W
authors.initials: CW
authors.lastname: Jung
authors.forename: Y S
authors.initials: YS
authors.lastname: Park
authors.forename: S S
authors.initials: SS
authors.lastname: Yoon
authors.forename: W K
authors.initials: WK
authors.lastname: Kang
authors.forename: M H
authors.initials: MH
authors.lastname: Lee
authors.forename: K
authors.initials: K
authors.lastname: Park
authors.forename: Y-H
authors.initials: YH
authors.lastname: Im
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D018943:Anthracyclines / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D000069287:Capecitabine; D016001:Confidence Intervals; D003627:Data Interpretation, Statistical; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D043823:Taxoids / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018943:Anthracyclines; D000964:Antimetabolites, Antineoplastic; D043823:Taxoids; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil